Lioresal (Baclofen)

Baclofen acts as an agonist at GABA_B receptors in the spinal cord and brainstem. Activation of these receptors opens potassium channels and reduces calcium influx, leading to neuronal hyperpolarisation and inhibition of excitatory neurotransmitter release, which dampens the reflex pathways that cause spastic muscle contractions.

The appropriate dose of Lioresal is individualized by the prescribing clinician based on the patient’s condition, response, and tolerability. Dosage is typically started low and titrated upward as needed, with adjustments made for renal function or other clinical factors.

Safety data for baclofen in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Healthcare providers should weigh potential benefits against possible risks and consider alternative therapies when treating pregnant or nursing individuals.

To request Lioresal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other muscle relaxants such as tizanidine or diazepam, baclofen specifically targets GABA_B receptors, offering a distinct mechanism that may provide better control of spasticity for some patients. Its side‑effect profile differs, with a lower risk of hepatic metabolism interactions but a higher potential for withdrawal symptoms if stopped abruptly.

Lioresal should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original packaging, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Lioresal is taken orally, usually as a tablet, with or without food as directed by the prescriber. Patients should follow the dosing schedule provided by their healthcare professional and avoid crushing or chewing the tablets unless specifically instructed.

The most serious risks include seizures, severe respiratory depression, and allergic reactions such as rash or angioedema. These events are rare but require immediate medical attention. Monitoring is essential, especially when initiating therapy or adjusting the dose.

Lioresal is contraindicated in individuals with known hypersensitivity to baclofen or any of its excipients. Caution is also advised for patients with severe renal impairment, uncontrolled epilepsy, or those taking other central nervous system depressants without close supervision.